Fundraising Fox

novamind

Toronto · Canada (Federal Level) corporation · 1 known investors

numinus.com ↗

Numinus provides psychedelic-assisted therapy and mental health treatment, focusing on preparation, guided experiences, and post-session integration for individuals. It positions psychedelics as medicines requiring careful clinical support rather than standalone treatments.

BiotechDigital HealthMental HealthWellness & Fitness

Founders & leadership

PNPayton Nyquvest
Payton NyquvestinFounder
JP
JING PENGNamed on SEC filing
Y(
YISROEL (SRULI) WEINREBNamed on SEC filing
JK
JESSE KAPLANNamed on SEC filing
PG
PRAKASH GOWDNamed on SEC filing
C(
CHARLES (CHUCK) RIFICINamed on SEC filing
SA
SENECA ANDERSONNamed on SEC filing
PT
PAUL THIELKINGNamed on SEC filing
PB
PIERRE BOU-MANSOURNamed on SEC filing
TW
TRACY WONGNamed on SEC filing
RR
REID ROBISONNamed on SEC filing
YC
YARON CONFORTINamed on SEC filing

Investors · 1

Clanton CapitalToronto · $350K – $1.5M

Reported raises · per SEC filings

Form D private placements

$8.8M disclosed across 3 rounds · 2020–2022

▶$4.7MraisedApr 2022 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse KaplanDirector
  • Dr. Reid RobisonExecutive Officer, Director
  • Paul ThielkingExecutive Officer
  • Nolan LadouceurExecutive Officer
  • Seneca AndersonExecutive Officer
  • Yaron ConfortiExecutive Officer, Director
  • Charles RificiDirector
  • Jing PengExecutive Officer
  • Samantha DeLenardoExecutive Officer
  • Prakash GowdExecutive Officer
  • Yisroel WeinrebDirector
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Dec 2020
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pierre Bou-MansourExecutive Officer
  • Charles RificiDirector
  • Yaron ConfortiExecutive Officer, Director
  • Nolan LadouceurExecutive Officer
  • Samantha DeLenardoExecutive Officer
  • Dr. Reid RobisonExecutive Officer, Director
  • Seneca AndersonExecutive Officer
  • Jing PengExecutive Officer
  • Paul ThielkingExecutive Officer
  • Prakash GowdExecutive Officer
  • Yisroel WeinrebDirector
  • Jesse KaplanDirector
Amount sold
$3.9M
Sales commissions
$314.6K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2022
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$164.5KraisedFeb 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JING PENGExecutive Officer
  • YISROEL (SRULI) WEINREBDirector
  • JESSE KAPLANDirector
  • PRAKASH GOWDExecutive Officer
  • CHARLES (CHUCK) RIFICIDirector
  • SENECA ANDERSONExecutive Officer
  • PAUL THIELKINGExecutive Officer
  • PIERRE BOU-MANSOURExecutive Officer
  • TRACY WONGExecutive Officer
  • REID ROBISONExecutive Officer, Director
  • YARON CONFORTIExecutive Officer, Director
  • NOLAN LADOUCEURExecutive Officer
Offering amount
$164.5K
Amount sold
$164.5K
First sale
Jan 2022
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does novamind do?
Numinus provides psychedelic-assisted therapy and mental health treatment, focusing on preparation, guided experiences, and post-session integration for individuals. It positions psychedelics as medicines requiring careful clinical support rather than standalone treatments.
Who founded novamind?
novamind was founded by Payton Nyquvest.
Who are novamind's investors?
novamind's investors include Clanton Capital.
How much funding has novamind raised?
novamind has disclosed $8.8M raised across 3 rounds.
Where is novamind headquartered?
novamind is headquartered in Toronto.